Literature DB >> 15225207

Controlling wound bioburden with a novel silver-containing Hydrofiber dressing.

Samantha A Jones1, Philip G Bowler, Michael Walker, David Parsons.   

Abstract

Clinicians now recognize that both aerobic and anaerobic microorganisms have the ability to degrade or damage host tissue at a wound site through the production of a variety of enzymes and toxins. Silver-containing dressings offer one method for controlling this polymicrobial wound bioburden, and research efforts are currently ongoing to determine their efficacy against aerobic, anaerobic, and antibiotic-resistant microorganisms. The current study aimed to determine the antimicrobial activity of a new silver-containing Hydrofiber dressing (AQUACEL Ag) on both aerobic and anaerobic microorganisms, using the zone-of-inhibition method. This method provides a measure of the ability of the dressing to make available a sufficient concentration of silver to have an antimicrobial effect. To some extent this test mimics the clinical use of the dressing and predicts its microbicidal activity at the wound-dressing interface. The results show that the silver-containing dressing makes silver available at a dressing-agar interface at a concentration that is effective against a broad range of aerobic, anaerobic, and antibiotic-resistant microorganisms. In the context of wound healing, the results showing antimicrobial activity against antibiotic-resistant microorganisms are particularly important, as the control and eradication of these organisms is a major concern within the health care profession.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225207     DOI: 10.1111/j.1067-1927.2004.012304.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  28 in total

Review 1.  Silver dressings: their role in wound management.

Authors:  David J Leaper
Journal:  Int Wound J       Date:  2006-12       Impact factor: 3.315

2.  Cytotoxicity of silver dressings on diabetic fibroblasts.

Authors:  Shi-Bo Zou; Won-Young Yoon; Seung-Kyu Han; Seong-Ho Jeong; Zheng-Jun Cui; Woo-Kyung Kim
Journal:  Int Wound J       Date:  2012-04-26       Impact factor: 3.315

3.  A novel green synthesis of silver nanoparticles using soluble starch and its antibacterial activity.

Authors:  Sobhy M Yakout; Ashraf A Mostafa
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns.

Authors:  Pornprom Muangman; Chanin Pundee; Supaporn Opasanon; Saipin Muangman
Journal:  Int Wound J       Date:  2010-05-28       Impact factor: 3.315

5.  Clinical safety and effectiveness evaluation of a new antimicrobial wound dressing designed to manage exudate, infection and biofilm.

Authors:  Daniel G Metcalf; David Parsons; Philip G Bowler
Journal:  Int Wound J       Date:  2016-03-22       Impact factor: 3.315

6.  Development of surface plasmon resonance-based sensor for detection of silver nanoparticles in food and the environment.

Authors:  Sabina Rebe Raz; Maria Leontaridou; Maria G E G Bremer; Ruud Peters; Stefan Weigel
Journal:  Anal Bioanal Chem       Date:  2012-03-27       Impact factor: 4.142

Review 7.  Activity of mesenchymal stem cells in therapies for chronic skin wound healing.

Authors:  Austin Nuschke
Journal:  Organogenesis       Date:  2013-12-10       Impact factor: 2.500

8.  Silver oxynitrate, an unexplored silver compound with antimicrobial and antibiofilm activity.

Authors:  Joe A Lemire; Lindsay Kalan; Alexandru Bradu; Raymond J Turner
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

9.  Electrospun polyurethane nanofibrous composite impregnated with metallic copper for wound-healing application.

Authors:  Saravana Kumar Jaganathan; Mohan Prasath Mani
Journal:  3 Biotech       Date:  2018-07-18       Impact factor: 2.406

10.  A review of the applications of the hydrofiber dressing with silver (Aquacel Ag) in wound care.

Authors:  Yoav Barnea; Jerry Weiss; Eyal Gur
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.